InvestorsHub Logo
Followers 177
Posts 24457
Boards Moderated 13
Alias Born 04/03/2002

Re: None

Thursday, 04/07/2005 2:00:18 PM

Thursday, April 07, 2005 2:00:18 PM

Post# of 87
MDM Group Receives ISTC Partner Status for Biodefense Division

MDM to Gain Access to Top Russian Facilities and Biodefense Development Opportunities Through ISTC Partnership

SANTA CLARA, CA, Apr 07, 2005 (MARKET WIRE via COMTEX) -- MDM Group, Inc. (OTC: MDDM) advises that it has received official notification of its registered status as "ISTC Partner". Partnership with the International Science and Technology Center (ISTC) provides MDM with clear access to accelerate its ongoing development of its biodefense capabilities in conjunction with world leading researchers and institutes in the Russian Federation.

The ISTC Program (http://www.istc.ru/) is part of a US Department of State program whose objective is to support nonproliferation in the area of nuclear, biological and chemical Weapons of Mass Destruction (WMD) by providing assistance in establishing sustainable non-weapon related jobs for the scientists and engineers in the Newly Independent States of the former Soviet Union who possess current or prior, direct or indirect WMD experience.

The ISTC program is funded mainly by the US, European Union, and Japan. Under the ISTC Partnership arrangement: -- ISTC will provide MDM with access to its vast network of institutesthroughout Russia and in six other neighboring countries;-- ISTC will provide coordination and project management services asrequired by MDM;-- Certain MDM projects will be eligible for risk-sharing arrangements toaccelerate commercialization.Since MDM's November 10, 2004 announcement of the establishment of its Biodefense Division, MDM's team has been developing its Biodefense strategy and evaluating several technology opportunities from sources around the world.

Consistent with its original mandate, MDM's focus is on niche projects in countermeasure development that have progressed from basic research to the development state. Such products are expected to have shorter development time and be confirmed as needed by the US government. MDM's Biodefense Division expects to engage in its first project during the current quarter. Dr. Ed Stephen, head of MDM's biodefense division, commented: "Our ISTC Partnership creates an immediate and important extension to the scientific capabilities and the facilities available to us. We are already well advanced in exploring specific opportunities in which ISTC can play a key role, saving us time and cost in some cases and introducing us to new intellectual property in other cases."

MDM Group is a development stage Company focused on the Security, Biodefense and Homeland Security industries.

For further information see: http://www.mdmgroupinc.com/

MDM Group is featured on http://www.homelanddefensestocks.com/ a global investment research portal for defense and security.

Contact: MDM Group, Inc.Trevor Ruehs 866-894-3910 Trevor @ mdmgroupinc.com

SOURCE: MDM Group, Inc Copyright 2005 Market Wire, All rights reserved.
-0-

SUBJECT CODE:
Aerospace and Defense:WeaponsGovernment:Security (law enforcement, homeland etc)Medical and Healthcare:Healthcare